ArticleBMC pulmonary medicine2026
Analysis of risk factors for frailty in older inpatients with interstitial lung disease.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo investigate the frailty status and associated risk factors in older patients diagnosed with interstitial lung disease (ILD).
methodsA total of 242 older ILD patients admitted to the hospital between April 2023 and April 2024 were recruited using a cluster sampling method. Comprehensive clinical data were collected, including information from the General Data Questionnaire, the Fried Frailty Phenotype (FFP) Scale, the Dyspnea Scale, the Hospital Anxiety and Depression Scale, the Pittsburgh Sleep Quality Index, and the Self-Efficacy for Managing Chronic Disease Scale. Based on the Fried criteria, participants were categorized into two groups: the frailty group (FFP ≥ 3) and the non-frailty group (FFP < 3).
resultsThe prevalence of frailty among older patients with ILD was found to be 38.02%. Multivariate analysis revealed that age (OR = 1.064), polypharmacy (OR = 2.479), poor sleep quality (OR = 5.687), and dyspnea (OR = 10.316) were independent risk factors for frailty (P < 0.05).
conclusionsFrailty in older patients with ILD is significantly associated with age, polypharmacy, poor sleep quality, and dyspnea. Healthcare professionals, particularly nursing staff, should closely monitor frailty indicators in this population and implement timely, targeted interventions to mitigate its development and progression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.